wr 1065 has been researched along with oxidopamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schor, NF | 1 |
| Haddadi, R; Jorjani, M; Khalifeh, S; Kheradmand, A; Nayebi, AM | 1 |
2 other study(ies) available for wr 1065 and oxidopamine
| Article | Year |
|---|---|
Mechanisms of synergistic toxicity of the radioprotective agent, WR2721, and 6-hydroxydopamine.
Topics: Acetylcysteine; Amifostine; Animals; Catalase; Drug Synergism; Eating; Free Radicals; Glutamate-Cysteine Ligase; Glutathione; Hydroxydopamines; Magnesium; Mercaptoethylamines; Mice; Mice, Inbred A; Organothiophosphorus Compounds; Oxidopamine; Peptide Synthases; Superoxide Dismutase; Time Factors | 1988 |
Effects of WR1065 on 6-hydroxydopamine-induced motor imbalance: Possible involvement of oxidative stress and inflammatory cytokines.
Topics: Animals; Disease Models, Animal; Glutathione; Inflammation; Interleukin-1beta; Lipid Peroxidation; Male; Malondialdehyde; Mercaptoethylamines; Motor Activity; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Parkinsonian Disorders; Pars Compacta; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2016 |